COMP <GO>
SKIN vs MRK // NET PROFIT MARGIN
SkinHealth Systems Inc. (Class A) (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: SKIN 0
— MRK 10
▲ NET PROFIT MARGIN LEADER: MRK
LAST: $9.94 (-2.07%) • MKT CAP: $66.0M
net-margins
-3.20%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
net-margins
28.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SKIN VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SKIN | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 65.30% | 74.80% | -9.50 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -26.90% | 20.70% | -47.60 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 3.42% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -6.90% | 34.30% | -41.20 | MRK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -3.20% | 28.10% | -31.30 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -10.00% | 1.30% | -11.30 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.19 | -4.99 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.8 | 51.7 | -15.86 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $66.0M | $361.02B | -$360.96B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SKIN REV | MRK REV | SKIN GROSS % | MRK GROSS % | SKIN FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $300.8M | $65.01B | 65.3% | 74.8% | $37.2M | $12.36B |
| FY 2024 | $334.3M | $64.17B | 54.5% | 76.3% | $15.4M | $18.10B |
| FY 2023 | $398.0M | $60.12B | — | — | $21.8M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SKIN // BETA —
MRK // BETA 0.92